Massimiliano Caiazzo is a molecular and cell biologist with specific expertise in stem cells, cellular neurobiology and mRNA-lipid nanoparticles.
The core expertise of his research lines is the use of developmental trascription factors to exert cell reprogramming of somatic cells.
This approach can be used to generate or modulate cells with therapeutic potential for cell replacement therapy purposes.
The main goal of his research lines is the generation of specialized neural and immune cells to treat neurodegenerative diseases using non-viral delivery systems.